Market Overview

From Earlier: Leerink Swann Downgrades Pharmacyclics, Inc. to Market Perform

Share:

Latest Ratings for PCYC

DateFirmActionFromTo
Mar 2015Leerink SwannDowngradesOutperformMarket Perform
Mar 2015NomuraDowngradesBuyNeutral
Mar 2015Wells FargoDowngradesOutperformMarket Perform

View More Analyst Ratings for PCYC
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (PCYC)

Around the Web, We're Loving...

Get Benzinga's Newsletters